| abstract |
Disclosed is the use of a ginseng extract, a ginsenoside and a ginsenoside derivative in the preparation of a medicine or health care product for the treatment of human cytomegalovirus infection-related diseases. The related diseases comprise a patient suffering from cardiovascular and cerebrovascular diseases, organ transfers, being perinatal, tumors, burns, AIDS and other diseases being infected by the human cytomegalovirus during treatment. Experiments demonstrate that the ginseng extract, the ginsenoside and the ginsenoside derivative are significant and quickly effective in the treatment of diseases of human cytomegalovirus infections, are less toxic and have less side effects, so that same are a safe, efficient, stable medicine or health care product with a simple preparation process for treating human cytomegalovirus virus infections, and are suitable for industrial production and easily propagated. They provide a new source of medicine for treating human cytomegalovirus infections. |